The White House released a health care plan Jan. 15 addressing drug prices, health insurance premiums and price transparency efforts. The plan includes codifying the administration’s “most favored nation” agreements recently reached with certain drugmakers, where companies must offer Americans the lowest cost paid for the same medications in other countries. It also calls for sending subsidies directly to Americans instead of insurance companies and funding cost-sharing reductions to reduce premiums. The plan would also require health insurers to publish rate and coverage comparisons on their websites “in plain English — not industry jargon” for consumers. In addition, the plan calls for any health provider or insurer accepting Medicare or Medicaid to “prominently” post their pricing and fees. 

Headline
Rep. Greg Landsman, D-Ohio, a member of the House Energy and Commerce Committee and its Subcommittee on Health, spoke with Mike Abrams, president and CEO of…
Headline
President Trump April 18 signed an executive order to accelerate research into psychedelic drugs for the treatment of serious mental illnesses, calling…
Headline
Americans across 43 states enrolled in health plans from the nation’s four largest commercial health insurers face potential disparities in finding in-network…
Headline
The U.S. Court of Appeals for the 5th Circuit April 9 affirmed rulings by a Mississippi district court that rejected requests by Novartis and PhRMA to enjoin…
Headline
The White House April 2 issued a proclamation implementing additional tariffs on certain patented pharmaceutical products and ingredients. The order imposes a…
Headline
The Centers for Medicare & Medicaid Services April 2 released a final rule on policy and technical changes to Medicare Advantage, the Medicare Prescription…